News
Company News: Curetis’ Subsidiary Ares Genetics and QIAGEN Enter into Bioinformatics Partnership to Fight Antimicrobial Resistance
— QIAGEN becomes exclusive partner for bioinformatics research applications based on ARESdb and AREStools
— Partnership intends to create a community platform for antimicrobial resistance research
Curetis N.V. (the “Company” and together with its subsidiaries “Curetis”), a developer of next-level molecular diagnostic solutions, today announced that its wholly-owned subsidiary Ares Genetics GmbH (Vienna, Austria) and QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) have entered into a strategic licensing agreement for ARESdb and AREStools in the area of antimicrobial resistance (AMR) research. Read more…
Innovation Radar: Understanding science / Testing CRISPR-Cas9 in the lab
Last weekend, akampion went back to the lab for a day to get a first-hand experience of genome editing. In an event organized by Science Bridge e.V. and supported by DFG, Joachim Herz Stiftung and Kassel University, selected participants were able to perform genome editing on an E. coli strain. Read more…
Heraeus PALACADEMY gets you into shape for cementing techniques and infection prevention
The courses and live events offered in 2019 by the Heraeus PALACADEMY provide orthopaedic and trauma surgeons, as well as specialist operating theatre staff, with many continuing education options for modern cementing techniques and infection management in arthroplasty. Registration is now open. Read more…
Company News: Curetis’ Partner Beijing Clear Biotech Submits Filing for Unyvero Approval in China
— Submission for Unyvero HPN Cartridge to Chinese regulatory authority NMPA includes U.S. and EU data
— Leverages recent changes in regulation allowing submission of foreign data
— Further collection of clinical data in China planned to support market access and adoption
Curetis N.V. (the “Company” and, together with its subsidiaries, “Curetis“), a developer of next-level molecular diagnostic solutions, today announced that Beijing Clear Biotech (BCB) has filed for regulatory approval of the Unyvero A50 HPN Application Cartridge for pneumonia with the Chinese National Medical Products Administration (NMPA; formerly Chinese Food and Drug Administration). Read more…